As filed with the Securities and Exchange Commission on August 7,
2020
Registration No. 333-
________________________________________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
_________________________________________
TEREX CORPORATION
(Exact name of registrant as specified in its charter)
_________________________________________
|
|
|
|
|
|
|
|
|
Delaware |
|
34-1531521 |
(State or other jurisdiction |
|
(I.R.S. Employer
|
of incorporation or organization) |
|
Identification No.) |
200 Nyala Farm Road
Westport, Connecticut 06880
(203) 222-7170
(Address and telephone number of principal executive
offices)
_________________________________________
Scott Posner, Esq.
Terex Corporation
200 Nyala Farm Road
Westport, Connecticut 06880
(203) 222-5984
(Name, address, and telephone number of agent for
service)
_________________________________________
Copies to:
Bryan Cave Leighton Paisner LLP
1290 Avenue on the Americas
New York, New York 10104
Attention:
David E. Fisher, Esq.
Andrew S. Rodman, Esq.
(212) 541-2000
_________________________________________
Approximate date of commencement of proposed sale to the
public:
From time to time after the effective date of this registration
statement.
_________________________________________
If the only securities being registered on this form are being
offered pursuant to dividend or interest reinvestment plans, please
check the following box.
If any of the securities being registered on this form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, other than securities offered only in
connection with dividend or interest reinvestment plans, please
check the following box.
If this form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration
statement number of the earlier effective registration statement
for the same offering.
If this form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, please check the following box and
list the Securities Act registration statement number of the
earlier effective registration statement for the same
offering.
If this Form is a registration statement pursuant to General
Instruction I.D. or a post-effective amendment thereto that shall
become effective upon filing with the Commission pursuant to Rule
462(e) under the Securities Act, check the following box.
If this Form is a post-effective amendment to a registration
statement filed pursuant to General Instruction I.D. filed to
register additional securities or additional classes of securities
pursuant to Rule 413(b) under the Securities Act, check the
following box.
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer,
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
|
|
|
|
|
|
Large accelerated filer
|
Accelerated filer
|
Non-accelerated filer
|
Smaller reporting company
|
|
Emerging growth company
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities
Act.
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of Each Class of Securities to be Registered (1) |
Amount to be Registered (2) (3) |
Proposed Maximum Offering Price Per Unit (2) (3) |
Proposed Maximum Aggregate Offering Price (2) (3) |
Amount of Registration Fee (4) |
Debt Securities |
- |
- |
- |
- |
Preferred Stock, par value $.01 per share |
- |
- |
- |
- |
Depositary Shares (5) |
- |
- |
- |
- |
Common Stock, par value $.01 per share |
- |
- |
- |
- |
Securities Warrants |
- |
- |
- |
- |
Total |
- |
- |
- |
- |
(1)Any
securities registered hereunder may be sold separately, together or
as units with other securities registered hereunder.
(2)An
indeterminate aggregate initial offering price or number of the
securities of each identified class is being registered as may from
time to time be offered at indeterminate prices. Separate
consideration may or may not be received for securities that are
issuable on exercise, conversion or exchange of other securities or
that are issued in units or represented by depositary shares.
Includes an indeterminate amount of our securities as may be issued
upon conversion of or exchange for, as the case may be, any other
securities registered under this registration
statement.
(3)Not
specified as to each class to be registered, pursuant to General
Instruction II.E of Form S-3.
(4)In
accordance with Rules 456(b) and 457(r) under the Securities Act,
we are deferring payment of all of the registration fee and will
pay the registration fee subsequently in advance or on a
“pay-as-you-go basis.”
(5)Each
depositary share registered hereunder will be issued under a
deposit agreement and will represent an interest in a fractional
share or multiple shares of preferred stock and will be evidenced
by a depositary receipt.
_________________________________________
Prospectus
TEREX CORPORATION
Debt Securities
Preferred Stock
Securities Warrants
Common Stock
Depositary Shares
_________________________________________
We may offer and sell, from time to time, in one or more offerings,
any combination of the securities we describe in this
prospectus.
We will provide the specific terms of these securities and
offerings in one or more supplements to this prospectus. The
prospectus supplement may also add, update or change information
contained in this prospectus. We urge you to read carefully this
prospectus, any accompanying prospectus supplement, any free
writing prospectus and any documents we incorporate by reference
before you make your investment decision. This prospectus may not
be used to sell securities unless accompanied by a prospectus
supplement.
We may offer and sell securities in one or more transactions from
time to time to or through underwriters, who may act as principals
or agents, directly to other purchasers or through agents or
dealers to other purchasers or through any combination of these
methods. The supplements to this prospectus will provide the
specific terms of the plan of distribution.
Our common stock is quoted on the New York Stock Exchange under the
symbol “TEX”. If we decide to list or seek a quotation for any
other securities, the prospectus supplement relating to those
securities will disclose the exchange or market on which those
securities will be listed or quoted.
Investing in our securities involves risks. You should consider the
risk factors incorporated herein by reference, described under the
heading “Risk Factors” beginning on page 4 of this prospectus and
described in any accompanying prospectus supplement and in any
related free writing prospectus.
_________________________________________
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed upon the adequacy or accuracy of this
prospectus. Any representation to the contrary is a criminal
offense.
_________________________________________
The date of this prospectus is August 7, 2020.
TABLE OF CONTENTS
Page
ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement that we filed
with the Securities and Exchange Commission, which we refer to as
the SEC, using the SEC's “shelf” registration rules. Under the
shelf registration rules, using this prospectus, together with any
prospectus supplement and any related free writing prospectus, we
may sell from time to time, in one or more offerings, any of the
securities described in this prospectus.
In this prospectus “Terex,” “we,” “us,” “our” and the “Company”
refer to Terex Corporation, a Delaware corporation, and its
consolidated subsidiaries, unless the context otherwise
requires.
This prospectus provides you with a general description of the
securities we may offer. Each time we offer securities under this
prospectus, we may provide a prospectus supplement that will
contain specific information about the terms and manner of that
offering. The prospectus supplement may also add, update or change
information contained in this prospectus. Any information contained
in the prospectus supplement that is inconsistent with this
prospectus will supersede the information in this prospectus. You
should read this prospectus, the applicable prospectus supplement,
any related free writing prospectus and the additional information
described below under “Where You Can Find Additional Information”
before making an investment decision. You should rely only on the
information contained or incorporated by reference in this
prospectus, any prospectus supplement and any related free writing
prospectus. We have not authorized any other person to provide you
with different information. If anyone provides you with different
or inconsistent information, you should not rely on it. We are not
making an offer to sell these securities in any jurisdiction where
the offer or sale is not permitted.
You should not assume that the information in this prospectus, any
accompanying prospectus supplement, any related free writing
prospectus or any documents we incorporate by reference is accurate
as of any date other than the date on the front of those documents.
Our business, financial condition, results of operations and
prospects may have changed since that date.
FORWARD-LOOKING STATEMENTS
This prospectus, any prospectus supplement and any documents we
incorporate by reference may include forward-looking statements
(within the meaning of Section 27A of the Securities Act of 1933,
as amended (the “Securities Act”), and Section 21E of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”))
regarding future events or our future financial performance that
involve certain contingencies and uncertainties. In addition, when
included in this prospectus, any prospectus supplement or any
documents incorporated herein by reference, the words “may,”
“should,” “expects,” “intends,” “anticipates,” “believes,” “plans,”
“projects,” “estimates” and the negatives thereof and analogous or
similar expressions are intended to identify forward-looking
statements. However, the absence of these words does not mean that
the statement is not forward-looking. We have based these
forward-looking statements on current expectations and projections
about future events. These statements are not guarantees of future
performance. Such statements are inherently subject to a variety of
risks and uncertainties that could cause actual results to differ
materially from those reflected in such forward-looking statements.
Such risks and uncertainties, many of which are beyond our control,
include, among others:
•our
business has been, and could be further, adversely impacted by an
outbreak of a new strain of coronavirus;
•our
business is cyclical and weak general economic conditions affect
the sales of our products and financial results;
•changes
in import/export regulatory regimes and the escalation of global
trade conflicts could continue to negatively impact sales of our
products and our financial results;
•our
financial results could be adversely impacted by the United
Kingdom’s departure from the European Union;
•changes
affecting the availability of the London Interbank Offered Rate may
have consequences on us that cannot yet reasonably be
predicted;
•our
need to comply with restrictive covenants contained in our debt
agreements;
•our
ability to generate sufficient cash flow to service our debt
obligations and operate our business;
•our
ability to access the capital markets to raise funds and provide
liquidity;
•our
business is sensitive to government spending;
•our
business is highly competitive and is affected by our cost
structure, pricing, product initiatives and other actions taken by
competitors;
•our
retention of key management personnel;
•the
financial condition of suppliers and customers, and their continued
access to capital;
•exposure
from providing financing and credit support for some of our
customers;
•we
may experience losses in excess of recorded reserves;
•we
are dependent on third-party-suppliers making us vulnerable to
supply shortages and price increases;
•our
business is global and subject to changes in exchange rates between
currencies, commodity price changes, regional economic conditions
and trade restrictions;
•our
operations are subject to a number of a potential risks that arise
from operating a multinational business, including compliance with
changing regulatory environments, the Foreign Corrupt Practices Act
and other similar laws, and political instability;
•a
material disruption to one of our significant
facilities;
•possible
work stoppages and other labor matters;
•compliance
with changing laws and regulations; particularly environmental and
tax laws and regulations;
•litigation,
product liability claims and other liabilities;
•our
ability to comply with an injunction and related obligations
imposed by the United States SEC;
•disruption
or breach in our information technology systems and storage of
sensitive data;
•our
ability to successfully implement our strategy; and
•other
factors.
Actual events or our actual future results may differ materially
from any forward-looking statement due to these and other risks,
uncertainties and significant factors. The forward-looking
statements contained herein speak only as of the date of this
prospectus and the forward-looking statements contained in
documents incorporated herein by reference speak only as of the
date of the respective documents. We expressly disclaim any
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statement contained or
incorporated
by reference in this prospectus to reflect any change in our
expectations with regard thereto or any change in events,
conditions or circumstances on which any such statement is
based.
WHERE YOU CAN FIND ADDITIONAL INFORMATION
We are a reporting company under the Exchange Act and file annual,
quarterly and current reports, proxy statements and other
information with the SEC. The public may obtain any documents that
we file electronically with the SEC at the SEC’s Internet web site,
http://www.sec.gov.
We also make available free of charge on or through our Internet
web site (http://www.terex.com) our Annual Reports on Form 10-K,
Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and,
if applicable, amendments to those reports filed or furnished
pursuant to Section 13(a) of the Exchange Act as soon as reasonably
practicable after we electronically file these materials with the
SEC. Except as set forth under “Incorporation of Certain Documents
by Reference,” information on our Internet website is not
incorporated into this prospectus by reference and should not be
considered a part of this prospectus. In addition, you may request
copies of these filings at no cost through our Investor Relations
Department at: Terex Corporation, 200 Nyala Farm Road, Westport,
Connecticut 06880, Attn: Investor Relations Department; Phone:
(203) 222-7170; or at our Internet web site.
We have filed with the SEC a registration statement on Form S-3
relating to the securities covered by this prospectus. This
prospectus is a part of the registration statement and does not
contain all the information in the registration statement. Whenever
a reference is made in this prospectus or any prospectus supplement
to a contract or other document of ours, the reference is only a
summary. For a copy of the contract or other document, you should
refer to the exhibits that are a part of the registration statement
or incorporated by reference into the registration statement by the
filing of a Form 8-K or otherwise. You may review a copy of the
registration statement and the documents we incorporate by
reference through the SEC’s Internet web site as listed
above.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The SEC allows us to “incorporate by reference” into this
prospectus information contained in documents that we file with it.
This means that we can disclose important information to you by
referring you to those documents. The information incorporated by
reference into this prospectus is an important part of this
prospectus, and information we file later with the SEC will
automatically update and supersede this information. We incorporate
by reference the documents listed below and any future filings we
will make with the SEC under Section 13(a), 13(c), 14 or 15(d) of
the Exchange Act between the date of this prospectus and the
termination of this offering; provided, however, that we are not
incorporating any information furnished under Item 2.02 or Item
7.01 of any Current Report on Form 8-K (or any corresponding
information or exhibits furnished under Item 9.01 to any such
Current Report on Form 8-K):
|
|
|
|
|
|
|
|
|
|
•
|
|
|
•
|
our Quarterly Report on Form
10-Q
for the quarterly period ended March 31, 2020 filed on May 1,
2020;
|
|
•
|
our Quarterly Report on Form
10-Q
for the quarterly period ended June 30, 2020 filed on August 3,
2020;
|
|
•
|
|
|
•
|
our Current Reports on Form 8-K filed on
January 17, 2020,
January 30, 2020,
March 25, 2020,
April 1, 2020,
April 20,2020,
April 24, 2020,
May 19, 2020,
June 9, 2020,
June 29, 2020,
and
August
7,
2020;
and
|
|
•
|
the description of our common stock on our Registration Statement
on Form 8-A filed on February 22, 1991, as updated by
Exhibit 4.4
to our Annual Report on Form 10-K for the fiscal year ended
December 31, 2019 filed on February 14, 2020, and as subsequently
amended or updated.
|
You may request a copy of these filings at no cost, by writing or
telephoning us as follows:
Terex Corporation
200 Nyala Farm Road
Westport, Connecticut 06880
Attn: Investor Relations Department
(203) 222-7170
You may also obtain a copy of these filings from our Internet web
site at
http://www.terex.com.
Please note, however, that the information on our Internet web
site, other than the documents listed above, is not incorporated
into this prospectus by reference and should not be considered a
part of this prospectus.
OUR COMPANY
Terex is a global manufacturer of aerial work platforms and
materials processing machinery. The Company designs, builds and
supports products used in construction, maintenance, manufacturing,
energy, minerals and materials management applications. Terex’s
products are manufactured in North and South America, Europe,
Australia and Asia and sold worldwide. The Company engages with
customers through all stages of the product life cycle, from
initial specification and financing to parts and service support.
The Company operates in two reportable segments: (i) Aerial Work
Platforms (“AWP”) and (ii) Materials Processing
(“MP”).
AWP designs, manufactures, services and markets aerial work
platform equipment, utility equipment, telehandlers and light
towers as well as their related components and replacement parts.
Customers use these products to construct and maintain industrial,
commercial, institutional and residential buildings and facilities,
for construction and maintenance of utility and telecommunication
lines, tree trimming, certain construction and foundation drilling
applications, and for other commercial operations, as well as in a
wide range of infrastructure projects.
MP designs, manufactures, services and markets materials processing
and specialty equipment, including crushers, washing systems,
screens, apron feeders, material handlers, pick and carry cranes,
rough terrain cranes, tower cranes, wood processing, biomass and
recycling equipment, concrete mixer trucks and concrete pavers,
conveyors, and their related components and replacement parts.
Customers use these products in construction, infrastructure and
recycling projects, in various quarrying and mining applications,
as well as in landscaping and biomass production industries,
material handling applications, maintenance applications to lift
equipment or material, moving materials and equipment on rugged or
uneven terrain, lifting construction material and placing material
at point of use.
The Company also assists customers in their rental, leasing and
acquisition of its products through Terex Financial Services
(“TFS”). TFS uses its equipment financing experience to provide
financing solutions to customers who purchase the Company’s
equipment.
Our principal offices are located at 200 Nyala Farm Road, Westport,
Connecticut 06880, and our telephone number is (203)
222-7170.
RISK FACTORS
Investing in our securities involves risks. Before making an
investment decision, you should carefully consider the specific
risks, uncertainties and other factors contained in this prospectus
and set forth in any applicable prospectus supplement and any
related free writing prospectus, and under the caption “Risk
Factors” under Item 1A of our Annual Report on Form 10-K for the
year ended December 31, 2019, which is incorporated by reference
into this prospectus, as supplemented and updated by subsequent
Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that
we have filed or will file with the SEC, which are incorporated by
reference into this prospectus and any other document that is
incorporated by reference into this prospectus or any applicable
prospectus supplement.
USE OF PROCEEDS
Unless indicated otherwise in any applicable prospectus supplement,
we expect to use the net proceeds from the sale of our securities
for our operations and for other general corporate purposes,
including repayment or refinancing of borrowings, working capital,
capital expenditures, investments, acquisitions and the repurchase
of our outstanding securities. Additional information on the use of
net proceeds from the sale of securities that we may offer from
time to time by this prospectus may be set forth in the applicable
prospectus supplement relating to a particular
offering.
DESCRIPTION OF THE SECURITIES WE MAY ISSUE
Overview
This prospectus describes the securities that we may offer from
time to time pursuant to this prospectus. The remainder of this
section provides some background information about the manner in
which the securities may be held. The three sections following this
section of the prospectus describe the terms of the basic
categories of securities that we may issue pursuant to this
prospectus:
|
|
|
|
|
|
|
|
|
|
•
|
our debt securities, which may be senior or
subordinated; |
|
•
|
warrants to purchase our debt securities, preferred stock,
depositary shares and common stock; and |
|
•
|
our common stock, preferred stock and depositary shares
representing fractional shares of our preferred stock. |
Prospectus Supplements
This prospectus provides you with a general description of the
securities we may offer. Each time we sell securities, we will
provide a prospectus supplement that will contain specific
information about the terms of that offering. The prospectus
supplement may also add to or change information contained in this
prospectus. If so, the prospectus supplement should be read as
superseding this prospectus. You should read both this prospectus
and any applicable prospectus supplement together with additional
information described under the heading “Where You Can Find
Additional Information.”
Any applicable prospectus supplement to be attached to the front of
this prospectus will describe the terms of any securities that we
offer, as well as the other specific terms related to that
offering. For more details on the terms of the securities, you
should read the exhibits filed with our registration statement, of
which this prospectus is a part, including any future filings we
will make with the SEC that are incorporated by reference into the
registration statement by filing a Form 8-K or
otherwise.
Legal Ownership of Securities
Holders of Securities
Book-Entry Holders.
We will issue debt securities under this prospectus in book-entry
form only, unless we specify otherwise in the applicable prospectus
supplement. We may, but are not obligated to, issue shares of
common stock, shares of preferred stock and securities warrants
under this prospectus in book-entry form. If securities are issued
in book-entry form, this means the securities will be represented
by one or more global securities registered in the name of a
financial institution that holds them as depositary on behalf of
other financial institutions that participate in the depositary's
book-entry system. These participating institutions, in turn, hold
beneficial interests in the securities on behalf of themselves or
their customers.
We will only recognize the person in whose name a security is
registered as the holder of that security. Consequently, for
securities issued in global form, we will recognize only the
depositary as the holder of the
securities, and all payments on the securities will be made to the
depositary. The depositary passes along the payments it receives to
its participants, which in turn pass the payments along to their
customers, who are the beneficial owners. The depositary and its
participants do so under agreements they have made with one another
or with their customers. They are not obligated to do so under the
terms of the securities.
As a result, investors of securities in book-entry form will not
own these securities directly. Instead, they will own beneficial
interests in a global security, through a bank, broker or other
financial institution that participates in the depositary's
book-entry system or holds an interest through a participant. As
long as the securities are issued in global form, investors will be
indirect holders, and not holders, of the securities. For more
information about securities issued in global form, see “— Global
Securities” below.
Street Name Holders.
Alternatively, we may initially issue securities under this
prospectus in non-global form. We may also terminate a global
security at any time after it is issued. In these cases, investors
may choose to hold their securities in their own names or in
“street name.” Securities held by an investor in street name would
be registered in the name of a bank, broker or other financial
institution that the investor chooses. In that event, the investor
would hold only a beneficial interest in those securities through
an account that the investor maintains at that
institution.
For securities held in street name, we will recognize only the
intermediary banks, brokers and other financial institutions in
whose names the securities are registered as the holders of those
securities and all payments on those securities will be made to
them. These institutions pass along the payments they receive to
their customers who are the beneficial owners, but only because
they agree to do so in their customer agreements or because they
are legally required to do so. Investors who hold securities in
street name will be indirect holders, not holders, of those
securities.
Legal Holders.
We, and any third parties employed by us or acting on your behalf,
including trustees, depositories and transfer agents, generally are
obligated only to the legal holders of the securities. In a number
of respects, we do not have obligations to investors who hold
beneficial interests in global securities, in street name or by any
other indirect means. This will be the case whether an investor
chooses to be an indirect holder of a security or has no choice
because we are issuing the securities only in global
form.
For example, once we make a payment or give a notice to the legal
holder, we have no further responsibility for the payment or notice
even if that legal holder is required, under agreements with
depositary participants or customers or by law, to pass it along to
the indirect holders but does not do so. Similarly, if we want to
obtain the approval of the holders to amend an indenture, to
relieve ourselves of the consequences of a default or of our
obligation to comply with a particular provision of the indenture
or for any other purpose, we would seek the approval only from the
legal holders, and not the indirect holders, of the securities.
Whether and how the legal holders contact the indirect holders is
determined by the legal holders.
When we refer to you, we mean those who invest in the securities
being offered by this prospectus, whether they are the legal
holders or only indirect holders of those securities. When we refer
to your securities, we mean the securities in which you hold a
direct or indirect interest.
Special Considerations for Indirect Holders.
If you hold securities through a bank, broker or other financial
institution, either in book-entry form or in street name, you
should check with your own institution to find out:
|
|
|
|
|
|
|
|
|
|
• |
how it handles securities payments and notices; |
|
• |
whether it imposes fees or charges; |
|
• |
how it would handle a request for the holders' consent, if ever
required; |
|
• |
whether and how you can instruct it to send you securities
registered in your own name so you can be a legal holder, if that
is permitted in the future; |
|
|
|
|
|
|
|
|
|
|
• |
how it would exercise rights under the securities if there were a
default or other event triggering the need for holders to act to
protect their interests; and |
|
• |
if the securities are in book-entry form, how the depositary's
rules and procedures will affect these matters. |
Global Securities
What is a Global Security?
A global security represents one or any other number of individual
securities. Generally, all securities represented by the same
global securities will have the same terms. We may, however, issue
a global security that represents multiple securities that have
different terms and are issued at different times. We call this
kind of global security a master global security.
Each security issued in book-entry form will be represented by a
global security that we deposit with and register in the name of a
financial institution that we select or its nominee. The financial
institution that is selected for this purpose is called the
depositary. Unless we specify otherwise in the applicable
prospectus supplement, The Depository Trust Company, New York, New
York, known as DTC, will be the depositary for all securities
issued in book-entry form. Beneficial interests in global
securities will be shown on, and transfers of global securities
will be reflected through, records maintained by DTC and its
participants.
A global security may not be transferred to or registered in the
name of anyone other than the depositary or its nominee, unless
special termination situations arise or as otherwise described in
the applicable prospectus supplement. We describe those situations
under “— Special Situations When a Global Security Will Be
Terminated” below. As a result of these arrangements, the
depositary, or its nominee, will be the sole registered owner and
holder of all securities represented by a global security, and
investors will be permitted to own only beneficial interests in a
global security. Beneficial interests must be held by means of an
account with a broker, bank or other financial institution that in
turn has an account with the depositary or with another institution
that does. Thus, an investor whose security is represented by a
global security will not be a holder of the security, but only an
indirect holder of a beneficial interest in the global
security.
Special Considerations for Global Securities.
As an indirect holder, an investor's rights relating to a global
security will be governed by the account rules of the investor's
financial institution and of the depositary, as well as general
laws relating to securities transfers. We do not recognize this
type of investor as a holder of securities and instead will deal
only with the depositary that holds the global
security.
If securities are issued only in the form of a global security, an
investor should be aware of the following:
|
|
|
|
|
|
|
|
|
|
• |
an investor cannot cause the securities to be registered in the
name of the investor, and cannot obtain physical certificates for
the investor’s interest in the securities, except in the special
situations we describe below; |
|
• |
an investor will be an indirect holder and must look to the
investor’s own broker, bank or other financial institution for
payments on the securities and protection of the investor’s legal
rights relating to the securities, as we describe under “— Legal
Ownership of Securities — Holders of Securities”
above;
|
|
• |
an investor may not be able to sell interests in the securities to
some insurance companies and to other institutions that are
required by law to own their securities in non-book-entry
form; |
|
• |
an investor may not be able to pledge the investor’s interest in a
global security in circumstances where certificates representing
the securities must be delivered to the lender or other beneficiary
of the pledge in order for the pledge to be effective; |
|
• |
the depositary's policies, which may change from time to time, will
govern payments, transfers, exchanges and other matters relating to
an investor's interest in a global security. Neither we nor any
third parties employed by us or acting on your behalf, including
trustees and transfer agents, have any responsibility for any
aspect of the depositary's actions or for its records of ownership
interests in a global security. Neither we, the trustee, the
transfer agent nor any other third parties supervise the depositary
in any way; |
|
|
|
|
|
|
|
|
|
|
• |
DTC requires that those who purchase and sell interests in a global
security within its book-entry system use immediately available
funds and your broker, bank or other financial institution may
require you to do so as well; and |
|
• |
brokers, banks and other financial institutions that participate in
the depositary's book-entry system, and through which an investor
holds its interest in a global security, may also have their own
policies affecting payments, notices and other matters relating to
the security. There may be more than one financial intermediary in
the chain of ownership for an investor. We do not monitor and are
not responsible for the actions of any of those
intermediaries. |
Special Situations When a Global Security Will Be
Terminated.
In some situations described below, a global security will be
terminated and interests in it will be exchanged for certificates
in non-global form representing the securities it represented.
After that exchange, the choice of whether to hold the securities
directly or in street name will be up to the investor. Investors
must consult their own banks or brokers to find out how to have
their interests in a global security transferred on termination to
their own names so that they will be holders. We have described the
rights of holders and street name investors above under “— Legal
Ownership of Securities — Holders of Securities”
above.
The special situations for termination of a global security are as
follows:
|
|
|
|
|
|
|
|
|
|
• |
if the depositary notifies us that it is unwilling, unable or no
longer qualified to continue as depositary for that global
security, and we do not appoint another institution to act as
depositary within a specified time period; or |
|
• |
if we elect to terminate that global security. |
A prospectus supplement may also list additional situations for
terminating a global security that would apply to that particular
series of securities covered by that prospectus supplement. If a
global security is terminated, the depositary has the sole
responsibility for determining the institutions in whose names the
securities represented by the global security will be registered
and, therefore, who will be the holders of those
securities.
DESCRIPTION OF THE DEBT SECURITIES
We may issue debt securities from time to time in one or more
distinct series. The debt securities will either be senior debt
securities or subordinated debt securities. Senior debt securities
will be issued under a senior indenture and subordinated debt
securities will be issued under a subordinated indenture. Unless
otherwise specified in the applicable prospectus supplement the
trustee under the indentures will be HSBC Bank USA, National
Association. We will include in a supplement to this prospectus the
specific terms of each series of debt securities being offered,
including the terms, if any, on which a series of debt securities
may be convertible into or exchangeable for common stock, preferred
stock or other debt securities. The statements and descriptions in
this prospectus or in any prospectus supplement regarding
provisions of the debt securities and their indentures are
summaries of these provisions, do not purport to be complete and
are subject to, and are qualified in their entirety by reference
to, all of the provisions of the debt securities, their indentures
(including any amendments or supplements we may enter into from
time to time which are permitted under each
indenture).
Unless otherwise specified in a prospectus supplement, the debt
securities will be direct unsecured obligations of Terex
Corporation, and, unless otherwise specified in a prospectus
supplement, the debt securities will not be guaranteed by any of
our subsidiaries. The senior debt securities will rank equally with
any of our other senior and unsubordinated debt. The subordinated
debt securities will be subordinate and junior in right of payment
to any senior indebtedness. There may be subordinated debt
securities that are senior or junior to other series of
subordinated debt securities.
The applicable prospectus supplement will set forth the terms of
each series of notes, including, if applicable:
|
|
|
|
|
|
|
|
|
|
• |
the title of the debt securities and whether the debt securities
will be senior debt securities or subordinated debt
securities; |
|
|
|
|
|
|
|
|
|
|
• |
any limit upon the aggregate principal amount of the debt
securities; |
|
• |
whether the debt securities will be issued as registered
securities, bearer securities or both, and any restrictions on the
exchange of one form of debt securities for another and on the
offer, sale and delivery of the debt securities in either
form; |
|
• |
the date or dates on which the principal amount of the debt
securities will mature; |
|
• |
if the debt securities bear interest, the rate or rates at which
the debt securities bear interest and the date or dates from which
interest will accrue; |
|
• |
if the debt securities bear interest, the dates on which interest
will be payable and the regular record dates for interest
payments; |
|
• |
the place or places where the payment of principal, any premium and
interest will be made, if other than or in addition to the Borough
of Manhattan, The City of New York, where the debt securities may
be surrendered for transfer or exchange and where notices or
demands to or upon us may be served; |
|
• |
any optional redemption provisions, which would allow us to redeem
the debt securities in whole or in part; |
|
• |
any sinking fund or other provisions that would obligate us to
redeem, repay or purchase the debt securities; |
|
• |
if the currency in which the debt securities will be issuable is
United States dollars, the denominations in which any registered
securities will be issuable, if other than denominations of $1,000
and any integral multiple thereof, and the denominations in which
any bearer securities will be issuable, if other than the
denomination of $5,000; |
|
• |
if other than the entire principal amount, the portion of the
principal amount of debt securities which will be payable upon a
declaration of acceleration of the maturity of the debt
securities; |
|
• |
the events of default and covenants relevant to the debt
securities, including, the inapplicability of any event of default
or covenant set forth in the indenture relating to the debt
securities, or the applicability of any other events of defaults or
covenants in addition to the events of default or covenants set
forth in the indenture relating to the debt securities; |
|
• |
if a person other than HSBC Bank USA, National Association is to
act as trustee for the debt securities, the name and location of
the corporate trust office of that trustee; |
|
• |
if other than United States dollars, the currency in which the debt
securities will be paid or denominated; |
|
• |
if the debt securities are to be payable, at our election or the
election of a holder of the debt securities, in a currency other
than that in which the debt securities are denominated or stated to
be payable, the terms and conditions upon which that election may
be made, and the time and manner of determining the exchange rate
between the currency in which the debt securities are denominated
or stated to be payable and the currency in which the debt
securities are to be so payable; |
|
• |
the designation of the original currency determination agent, if
any; |
|
• |
if the debt securities are issuable as indexed securities, the
manner in which the amount of payments of principal, any premium
and interest will be determined; |
|
• |
if the debt securities do not bear interest, the dates on which we
will furnish to the trustee the names and addresses of the holders
of the debt securities; |
|
• |
if other than as set forth in the indenture, provisions for the
satisfaction and discharge or defeasance or covenant defeasance of
that indenture with respect to the debt securities issued under
that indenture; |
|
• |
the date as of which any bearer securities and any global security
will be dated if other than the date of original issuance of the
first debt security of a particular series to be
issued; |
|
• |
whether and under what circumstances we will pay additional amounts
to non-United States holders in respect of any tax assessment or
government charge; |
|
|
|
|
|
|
|
|
|
|
• |
whether the debt securities will be issued in whole or in part in
the form of a global security or securities and, in that case, any
depositary and global exchange agent for the global security or
securities, whether the global form shall be permanent or temporary
and, if applicable, the exchange date; |
|
• |
if debt securities are to be issuable initially in the form of a
temporary global security, the circumstances under which the
temporary global security can be exchanged for definitive debt
securities and whether the definitive debt securities will be
registered securities, bearer securities or will be in global form
and provisions relating to the payment of interest in respect of
any portion of a global security payable in respect of an interest
payment date prior to the exchange date; |
|
• |
the extent and manner to which payment on or in respect of debt
securities will be subordinated to the prior payment of our other
liabilities and obligations; |
|
• |
whether payment of any amount due under the debt securities will be
guaranteed by one or more guarantors, including one or more of our
subsidiaries; |
|
• |
whether the debt securities will be convertible and the terms of
any conversion provisions; |
|
• |
the forms of the debt securities; |
|
• |
a discussion of any material United States federal income tax
consequences of owning and disposing of the debt securities;
and |
|
• |
any other terms of the debt securities, which terms shall not be
inconsistent with the requirements of the Trust Indenture Act of
1939, as amended. |
This prospectus is part of a registration statement that does not
limit the aggregate principal amount of debt securities that we may
issue and provides that we may issue debt securities from time to
time in one or more series under one or more indentures, in each
case with the same or various maturities, at par or at a discount.
Unless indicated in a prospectus supplement, we may issue
additional debt securities of a particular series without the
consent of the holders of the debt securities of such series
outstanding at the time of the issuance. Any such additional debt
securities, together with all other outstanding debt securities of
that series, will constitute a single series of debt securities
under the applicable indenture.
We intend to disclose any restrictive covenants for any issuance or
series of debt securities in the applicable prospectus
supplement.
DESCRIPTION OF THE CAPITAL STOCK
Our authorized capital stock consists of 350,000,000 shares of
capital stock, consisting of 300,000,000 shares of common stock,
par value $.01 per share, and 50,000,000 shares of preferred stock,
par value $.01 per share. As of June 30, 2020, there were
82,862,552 shares of common stock issued, of which, 13,558,213 were
held in treasury and 69,304,339 shares of common stock were
outstanding. Of the unissued shares of common stock at that date,
4,102,254 shares were reserved for issuance for the exercise of
stock options and the vesting of restricted stock. As of June 30,
2020, there were no shares of preferred stock
outstanding.
Common Stock
The following is a summary of the material terms of our common
stock. Because it is only a summary, it does not contain all the
information that may be important to you. Accordingly, you should
read carefully the more detailed provisions of our restated
certificate of incorporation, as amended (“restated certificate of
incorporation”), and amended and restated bylaws.
Each outstanding share of our common stock entitles the holder to
one vote, either in person or by proxy, on all matters submitted to
a vote of stockholders, including the election of directors. There
is no cumulative voting in the election of directors, which means
that the holders of a majority of the outstanding shares of common
stock can elect all of the directors then standing for election.
Subject to preferences which may be applicable to any
outstanding shares of preferred stock, holders of common stock have
equal ratable rights to any dividends that may be declared by the
board of directors out of legally available funds.
Holders of our common stock have no conversion, redemption or
preemptive rights to subscribe for any of our securities. All
outstanding shares of our common stock are fully paid and
nonassessable. In the event of any liquidation, dissolution or
winding-up of our affairs, holders of our common stock will be
entitled to share ratably in our assets remaining after provision
for payment of liabilities to creditors and preferences applicable
to outstanding shares of preferred stock. The rights, preferences
and privileges of holders of our common stock are subject to the
rights of the holders of any outstanding shares of preferred
stock.
Our amended and restated bylaws provide that our stockholders must
provide prior notice for nominations for election to the board of
directors or for proposing matters which can be acted upon at
stockholders meeting. This provision could be considered an
“anti-takeover”
provision.
Our common stock is traded on the New York Stock Exchange under the
symbol “TEX”.
The transfer agent and registrar for our common stock is American
Stock Transfer & Trust Company.
Preferred Stock and
Depositary Shares Representing Fractional Shares of Preferred
Stock
The following describes the general terms and provisions of the
preferred stock we may offer by this prospectus. The applicable
prospectus supplement will describe the specific terms of the
series of the preferred stock then offered, and the terms and
provisions described in this section will apply only to the extent
not superseded by the terms of the applicable prospectus
supplement.
This section is only a summary of the preferred stock that we may
offer. We urge you to read carefully our restated certificate of
incorporation and the certificate of designation we will file in
relation to an issue of any particular series of preferred stock
before you buy any preferred stock.
Our board of directors may, without further action of the
stockholders, determine the following for each series of preferred
stock, and any applicable prospectus supplement will
describe:
|
|
|
|
|
|
|
|
|
|
• |
the distinctive serial designation and the number of
shares; |
|
• |
the dividend rate or rates, whether dividends shall be cumulative
and, if so, from what date, the payment date or dates for
dividends, and any participating or other special rights with
respect to dividends; |
|
• |
any voting powers of the shares; |
|
• |
whether the shares will be redeemable and, if so, the price or
prices at which, and the terms and conditions on which, the shares
may be redeemed; |
|
• |
the amount or amounts payable upon the shares in the event of
voluntary or involuntary liquidation, dissolution or winding up of
us prior to any payment or distribution of our assets to any class
or classes of our stock ranking junior to the preferred
stock; |
|
• |
whether the shares will be entitled to the benefit of a sinking or
retirement fund and, if so entitled, the amount of the fund and the
manner of its application, including the price or prices at which
the shares may be redeemed or purchased through the application of
the fund; |
|
• |
whether the shares will be convertible into, or exchangeable for,
shares of any other class or of any other series of the same or any
other class of our stock or the stock of another issuer, and if so
convertible or exchangeable, the conversion price or prices, or the
rates of exchange, and any adjustments to the conversion price or
rates of exchange at which the conversion or exchange may be made,
and any other terms and conditions of the conversion or exchange;
and |
|
|
|
|
|
|
|
|
|
|
• |
any other preferences, privileges and powers, and relative,
participating, optional, or other special rights, and
qualifications, limitations or restrictions, as our board of
directors may deem advisable and as shall not be inconsistent with
the provisions of our restated certificate of
incorporation. |
The preferred stock, when issued, will be fully paid and
non-assessable. Unless the applicable prospectus supplement
provides otherwise, the preferred stock will have no preemptive
rights to subscribe for any additional securities which may be
issued by us in the future. The transfer agent and registrar for
the preferred stock and any depositary shares will be specified in
the applicable prospectus supplement.
We may elect to offer depositary shares represented by depositary
receipts. If we so elect, each depositary share will represent a
fractional interest in a share of preferred stock with the amount
of the fractional interest to be specified in the applicable
prospectus supplement. If we issue depositary shares representing
interests in shares of preferred stock, those shares of preferred
stock will be deposited with a depositary.
The shares of any series of preferred stock underlying the
depositary shares will be deposited under a separate deposit
agreement between us and a bank or trust company having its
principal office in the United States and having a combined capital
and surplus of at least $50 million. The applicable prospectus
supplement will set forth the name and address of the depositary.
Subject to the terms of the deposit agreement, each owner of a
depositary share will have a fractional interest in all the rights
and preferences of the preferred stock underlying the depositary
share. Those rights include any dividend, voting, redemption,
conversion and liquidation rights.
The depositary shares will be evidenced by depositary receipts
issued under the deposit agreement. If you purchase fractional
interests in shares of the related series of preferred stock, you
will receive depositary receipts as described in the applicable
prospectus supplement. While the final depositary receipts are
being prepared, we may order the depositary to issue temporary
depositary receipts substantially identical to the final depositary
receipts although not in final form. The holders of the temporary
depositary receipts will be entitled to the same rights as if they
held the depositary receipts in final form. Holders of the
temporary depositary receipts can exchange them for the final
depositary receipts at our expense.
DESCRIPTION OF THE SECURITIES WARRANTS
This section describes the general terms and provisions of the
securities warrants that we may offer by this prospectus. The
applicable prospectus supplement will describe the specific terms
of the securities warrants then offered, and the terms and
provisions described in this section will apply only to the extent
not superseded by the terms of the applicable prospectus
supplement.
We may issue securities warrants for the purchase of senior debt
securities, subordinated debt securities, preferred stock,
depositary shares or common stock. Securities warrants may be
issued alone or together with senior debt securities, subordinated
debt securities, preferred stock, depositary shares or common stock
offered by any prospectus supplement and may be attached to or
separate from those securities. Each series of securities warrants
will be issued under warrant agreements between us and a bank or
trust company, as warrant agent, which will be described in the
applicable prospectus supplement. The warrant agent will act solely
as our agent in connection with the securities warrants and will
not act as an agent or trustee for any holders or beneficial
holders of securities warrants.
If securities warrants for the purchase of senior debt securities
or subordinated debt securities are offered, the applicable
prospectus supplement will describe the terms of those securities
warrants, including the following if applicable:
|
|
|
|
|
|
|
|
|
|
• |
the offering price; |
|
• |
the currencies in which the securities warrants are being
offered; |
|
|
|
|
|
|
|
|
|
|
• |
the designation, aggregate principal amount, currencies,
denominations and terms of the series of the senior debt securities
or subordinated debt securities that can be purchased upon
exercise; |
|
• |
the designation and terms of any series of senior debt securities
or subordinated debt securities with which the securities warrants
are being offered and the number of securities warrants offered
with each senior debt security or subordinated debt
security; |
|
• |
the date, if any, on and after which the holder of the securities
warrants can transfer them separately from the series of senior
debt securities or subordinated debt securities; |
|
• |
the principal amount of the series of senior debt securities or
subordinated debt securities that can be purchased upon exercise
and the price at which and currencies in which the principal amount
may be purchased upon exercise; |
|
• |
the date on which the right to exercise the securities warrants
begins and the date on which the right expires; and |
|
• |
any other terms of the securities warrants. |
If securities warrants for the purchase of preferred stock are
offered, the applicable prospectus supplement will also describe
the terms of the preferred stock into which the securities warrants
are exercisable as described under “Description of the Capital
Stock – Preferred Stock and Depositary Shares Representing
Fractional Shares of Preferred Stock.”
PLAN OF DISTRIBUTION
General
We may offer and sell the securities in one or more transactions
from time to time to or through underwriters or dealers, who may
act as principals or agents, directly to other purchasers or
through agents or dealers to other purchasers, through any
combination of these methods, or through any other means described
in a prospectus supplement.
A prospectus supplement relating to a particular offering of
securities may include the following information:
|
|
|
|
|
|
|
|
|
|
• |
the terms of the offering; |
|
|
|
|
|
|
|
|
|
|
• |
the names of any underwriters, dealers or agents; |
|
|
|
|
|
|
|
|
|
|
• |
the purchase price of the securities; |
|
|
|
|
|
|
|
|
|
|
• |
the net proceeds to us from the sale of the securities; |
|
|
|
|
|
|
|
|
|
|
• |
any delayed delivery arrangements; |
|
|
|
|
|
|
|
|
|
|
• |
any underwriting discounts and other items constituting
underwriters’ compensation; |
|
|
|
|
|
|
|
|
|
|
• |
any initial public offering price; and |
|
|
|
|
|
|
|
|
|
|
• |
any discounts or concessions allowed or reallowed or paid to
dealers. |
Any initial public offering prices, discounts or concessions
allowed or reallowed or paid to dealers may be changed from time to
time.
The distribution of the securities may be effected from time to
time in one or more transactions at a fixed price or prices, which
may be changed, at market prices prevailing at the time of sale, at
prices related to prevailing market prices or at negotiated prices
in block trades, or in underwritten offerings or in other types of
trades.
Underwriting Compensation
We may offer these securities to the public through
underwriting syndicates represented by managing underwriters or
through underwriters without an underwriting syndicate. If
underwriters are used for the sale of securities, the securities
will be acquired by the underwriters for their own account. The
underwriters may resell the securities from time to time in one or
more transactions, including in negotiated transactions at a fixed
public offering price or at varying prices determined at the time
of sale. The offered securities may be offered either to the public
through underwriting syndicates represented by one or more managing
underwriters or by one or more underwriters without a syndicate. In
connection with any such underwritten sale of securities,
underwriters may receive compensation from us or from purchasers
for whom they may act as agents, in the form of discounts,
concessions or commissions. Underwriters may sell securities to or
through dealers, and the dealers may receive compensation in the
form of discounts, concessions or commissions from the underwriters
and/or commissions from the purchasers for whom they may act as
agents.
Offered securities may be sold directly by us to one or more
institutional purchasers, or through agents designated by us from
time to time, at a fixed price or prices, which may be changed, or
at varying prices determined at the time of sale. Any agent
involved in the offer or sale of the offered securities in respect
of which this prospectus is delivered will be named, and any
commissions payable by us to such agent will be set forth, in the
prospectus supplement relating to that offering. Unless otherwise
indicated in such prospectus supplement, any such agent will be
acting on a best efforts basis for the period of its
appointment.
If we use an underwriter or underwriters in the sale of
particular securities, we will execute an underwriting agreement
with those underwriters at the time of sale of those securities.
The names of the underwriters will be set forth in the prospectus
supplement used by the underwriters to sell those securities.
Unless otherwise indicated in the prospectus supplement relating to
a particular offering of securities, the obligations of the
underwriters to purchase the securities will be subject to
customary conditions precedent and the underwriters will be
obligated to purchase all of the securities offered if any of the
securities are purchased.
Underwriters, dealers and agents that participate in the
distribution of securities may be deemed to be underwriters under
the Securities Act. Any discounts or commissions that they receive
from us and any profit that they receive on the resale of
securities may be deemed to be underwriting discounts and
commissions under the Securities Act. If any entity is deemed an
underwriter or any amounts deemed underwriting discounts and
commissions, the prospectus supplement will identify the
underwriter or agent and describe the compensation received from
us.
Indemnification
We may enter into agreements under which underwriters and agents
who participate in the distribution of securities may be entitled
to indemnification by us against various liabilities, including
liabilities under the Securities Act of 1933, and to contribution
with respect to payments which the underwriters, dealers or agents
may be required to make.
Related
Transactions
Various of the underwriters, dealers and agents who participate in
the distribution of securities, and their affiliates, may perform
various commercial banking and investment banking services for us
or our affiliates from time to time in the ordinary course of
business.
Delayed Delivery Contracts
We may authorize underwriters or other persons acting as our agents
to solicit offers by institutions to purchase securities from us
pursuant to contracts providing for payment and delivery on a
future date. These institutions may include commercial and savings
banks, insurance companies, pension funds, investment companies,
educational and charitable institutions and others, but in all
cases we must approve these institutions. The obligations of any
purchaser under any of these contracts will be subject to the
condition that the purchase of the securities shall not at the time
of delivery be prohibited under the laws of the jurisdiction to
which such purchaser is subject. The underwriters and other agents
will not have any responsibility in respect of the validity or
performance of these contracts.
Price
Stabilization and Short Positions
If underwriters or dealers are used in the sale, until the
distribution of the securities is completed, rules of the SEC may
limit the ability of any underwriters to bid for and purchase the
securities. As an exception to these rules, representatives of any
underwriters are permitted to engage in transactions that stabilize
the price of the securities. These transactions may consist of bids
or purchases for the purpose of pegging, fixing or maintaining the
price of the securities. If the underwriters create a short
position in the securities in connection with the offering (that
is, if they sell more securities than are set forth on the cover
page of the prospectus supplement) the representatives of the
underwriters may reduce that short position by purchasing
securities in the open market.
These transactions may be effected on the New York Stock Exchange,
in the over-the-counter market, or otherwise. Underwriters are not
required to engage in any of these activities, or to continue such
activities if commenced.
LEGAL MATTERS
Unless otherwise specified in a prospectus supplement, the validity
of any securities issued hereunder will be passed upon for us by
Bryan Cave Leighton Paisner
LLP, New York, New York.
EXPERTS
The consolidated financial statements incorporated in this
prospectus by reference to Terex Corporation’s Current Report on
Form 8-K dated August 7, 2020, and management’s assessment of the
effectiveness of internal control over financial reporting (which
is included in Management’s Annual Report on Internal Control over
Financial Reporting) incorporated in this prospectus by reference
to the Annual Report on Form 10-K for the year ended December 31,
2019 have been so incorporated in reliance on the report of
PricewaterhouseCoopers LLP, an independent registered public
accounting firm, given on the authority of said firm as experts in
auditing and accounting.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution
The following table sets forth all fees and expenses payable by the
Registrants in connection with the issuance and distribution of the
securities being registered hereby (other than underwriting
discounts and commissions).
|
|
|
|
|
|
|
|
|
SEC registration fee
|
$ |
(1)
|
Printing and engraving expenses
|
$ |
(2)
|
Legal fees and expenses |
$ |
(2)
|
Accounting fees and expenses
|
$ |
(2)
|
Trustee's fees and expenses
|
$ |
(2)
|
Blue sky fees and expenses
|
$ |
(2)
|
Rating agency fees |
$ |
(2)
|
Miscellaneous |
$ |
(2)
|
Total
|
$ |
(2)
|
(1) Deferred in reliance on Rules 456(b) and 457(r) under the
Securities Act of 1933.
(2) The amount of securities and number of offerings are
indeterminable and the expenses cannot be estimated at this time.
An estimate of the aggregate expenses in connection with the sale
and distribution of securities being offered will be included in
any applicable prospectus supplement.
Item 15. Indemnification of Officers and Directors
Section 145 of the Delaware General Corporation Law (“DGCL”) and
Terex's amended and restated by-laws provide for the
indemnification of Terex's directors and officers in a variety of
circumstances, which may include liabilities under the Securities
Act of 1933.
Terex's amended and restated by-laws generally requires Terex to
indemnify its officers and directors against all liabilities
(including judgments, settlements, fines and penalties) and
reasonable expenses incurred in connection with the investigation,
defense, settlement or appeal of certain actions, whether
instituted by a third party or a stockholder (either directly or
indirectly) and including specifically, but without limitation,
actions brought under the Securities Act of 1933, and/or the
Exchange Act; except that no such indemnification will be permitted
if such director or officer was not successful in defending against
any such action and it is determined that the director or officer
breached or failed to perform his or her duties to Terex, and such
breach or failure constitutes (i) a willful breach of his or her
“duty of loyalty”, (ii) acts or omissions not in good faith or
involving intentional misconduct or a knowing violation of the law,
(iii) a violation of Section 174 of the DGCL, relating to
prohibited dividends or distributions or the repurchase or
redemption of stock or (iv) a transaction where such individual
derived an improper financial profit (unless it is deemed that such
profit is immaterial in light of all of the circumstances)
(collectively, “Breach of Duty”). Notwithstanding the foregoing,
subject to certain exceptions, the amended and restated by-laws
provide that directors or officers initiating an action are not
entitled to indemnification.
The amended and restated by-laws of Terex also establish certain
procedures by which (i) a director or
officer may request an advance on his or her reasonable expenses,
prior to the final disposition of an action, (ii) Terex may
withhold an indemnification payment from a director or officer,
(iii) a director or officer may be entitled to partial
indemnification and (iv) a director or officer may challenge
Terex's denial to furnish him or her with requested
indemnification. Additionally, the restated by-laws provide that
the adverse termination of an action against an officer or
director, is not in and of itself sufficient to create a
presumption that a director or officer engaged in conduct
constituting a Breach of Duty.
Finally, Terex's restated certificate of incorporation contains a
provision which eliminates the personal liability of a director to
Terex and its stockholders for certain breaches of his or her
fiduciary duty of care as a director. This provision does not,
however, eliminate or limit the personal liability of a director
(i) for any breach of such director's “duty of loyalty” (as further
defined therein) to Terex or its stockholders, (ii) for acts or
omissions not in “good faith” (as further defined therein) or which
involve intentional misconduct or a knowing violation of law, (iii)
under Section 174 of the DGCL, relating in general to the willful
or negligent payment of an illegal dividend or the authorization of
an unlawful stock repurchase or redemption, or (iv) for any
transaction from which the director derived an improper personal
profit to the extent of such profit. This provision of the restated
certificate of incorporation offers persons who serve on the Board
of Directors of Terex protection against awards of monetary damages
resulting from negligent (except as indicated above) and “grossly”
negligent actions taken in the performance of their duty of care,
including grossly negligent business decisions made in connection
with takeover proposals for Terex. As a result of this provision,
the ability of Terex or a stockholder thereof to successfully
prosecute an action against a director for a breach of his duty of
care has been limited. However, the provision does not affect the
availability of equitable remedies such as an injunction or
rescission based upon a director's breach of his duty of
care.
Terex maintains a directors' and officers' insurance policy
which insures the officers and directors of Terex from any claim
arising out of an alleged wrongful act by such persons in their
respective capacities as officers and directors of
Terex.
Any underwriting agreements that we may enter into will
likely provide for the indemnification of Terex, its controlling
persons, its directors and certain of its officers by the
underwriters against certain liabilities, including liabilities
under the Securities Act of 1933.
It is the opinion of the SEC that indemnification of directors and
officers for liabilities arising under the Securities Act is
against public policy and is unenforceable pursuant to Section 14
of the Securities Act.
Item 16. Exhibits
See Exhibit Index immediately following the signature page hereof,
which is incorporated herein by reference.
Item 17. Undertakings
The undersigned Registrant hereby undertakes:
(a) (1) To
file, during any period in which offers or sales are being made, a
post-effective amendment to this registration
statement:
(i) To include any
prospectus required by Section 10(a)(3) of the Securities Act of
1933;
(ii) To reflect in the
prospectus any facts or events arising after the effective date of
the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate,
represent a fundamental change in the information set forth in the
registration statement. Notwithstanding the foregoing, any increase
or decrease in volume of securities offered (if the total dollar
value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the
estimated maximum
offering range may be reflected in the form of prospectus filed
with the SEC pursuant to Rule 424(b) if, in the aggregate, the
changes in volume and price represent no more than a 20 percent
change in the maximum aggregate offering price set forth in the
“Calculation of Registration Fee” table in the effective
registration statement; and
(iii) To include any material
information with respect to the plan of distribution not previously
disclosed in the registration statement or any material change to
such information in the registration statement;
provided, however,
that paragraphs (i), (ii) and (iii) do not apply if the information
required to be included in a post-effective amendment by those
paragraphs is contained in reports filed with or furnished to the
SEC by the Registrant pursuant to Section 13 or Section 15(d) of
the Exchange Act that are incorporated by reference in the
registration statement, or is contained in a form of prospectus
filed pursuant to Rule 424(b) that is part of the registration
statement.
(2) That, for the
purpose of determining any liability under the Securities Act of
1933, each such post-effective amendment shall be deemed to be a
new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be
deemed to be the initial
bona fide
offering thereof.
(3) To remove from
registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination
of the offering.
(4) That, for the purpose
of determining liability under the Securities Act of 1933 to any
purchaser:
(i) Each prospectus filed
by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be
part of the registration statement as of the date the filed
prospectus was deemed part of and included in the registration
statement; and
(ii) Each prospectus
required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7)
as part of a registration statement in reliance on Rule 430B
relating to an offering made pursuant to Rule 415(a)(1)(i), (vii)
or (x) for the purpose of providing the information required by
Section 10(a) of the Securities Act of 1933 shall be deemed to be
part of and included in the registration statement as of the
earlier of the date such form of prospectus is first used after
effectiveness or the date of the first contract of sale of
securities in the offering described in the prospectus. As provided
in Rule 430B, for liability purposes of the issuer and any person
that is at that date an underwriter, such date shall be deemed to
be a new effective date of the registration statement relating to
the securities in the registration statement to which the
prospectus relates, and the offering of such securities at that
time shall be deemed to be the initial
bona fide
offering thereof.
Provided, however,
that no statement made in a registration statement or prospectus
that is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the
registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of
contract of sale prior to such effective date, supersede or modify
any statement that was made in the registration statement or
prospectus that was part of the registration statement or made in
any such document immediately prior to such effective
date.
(5) That, for the purpose
of determining liability of a Registrant under the Securities Act
to any purchaser in the initial distribution of the securities, the
undersigned Registrant undertakes that in a primary offering of
securities of the undersigned Registrant pursuant to this
registration statement, regardless of the underwriting method used
to sell the securities to the purchaser, if the securities are
offered or sold to such purchaser by means of any of the following
communications, the undersigned Registrant will be a seller to the
purchaser and will be considered to offer or sell such securities
to such purchaser:
(i) Any preliminary
prospectus or prospectus of the undersigned Registrant relating to
the offering required to be filed pursuant to Rule
424;
(ii) Any free writing
prospectus relating to the offering prepared by or on behalf of the
undersigned Registrant or used or referred to by the undersigned
Registrant;
(iii) The portion of any other
free writing prospectus relating to the offering containing
material information about the undersigned Registrant or its
securities provided by or on behalf of the undersigned Registrant;
and
(iv) Any other communication
that is an offer in the offering made by the undersigned Registrant
to the purchaser.
(b) That, for purposes of
determining any liability under the Securities Act, each filing of
the Registrant’s annual report pursuant to Section 13(a) or 15(d)
of the Exchange Act (and, where applicable, each filing of an
employee benefit plan’s annual report pursuant to Section 15(d) of
the Exchange Act) that is incorporated by reference in the
registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the
initial
bona fide
offering thereof.
(c) To file an
application for the purpose of determining the eligibility of the
trustee to act under subsection (a) of Section 310 of the Trust
Indenture Act in accordance with the rules and regulations
prescribed by the SEC under Section 305(b)(2) of the Trust
Indenture Act of 1939, amended.
Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and
controlling persons of the Registrant pursuant to the foregoing
provisions, or otherwise, the Registrant has been advised that in
the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant
of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its
counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in
the Securities Act and will be governed by the final adjudication
of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-3 and has
duly caused this Registration Statement to be signed on its behalf
by the undersigned, thereunto duly authorized, in the City of
Westport, State of Connecticut, on August 7, 2020.
TEREX CORPORATION
(Registrant)
John L. Garrison
Chairman, President and Chief Executive Officer
POWERS OF ATTORNEY
KNOW
ALL PERSONS BY THESE PRESENTS, that each individual whose signature
appears below hereby constitutes and appoints John L. Garrison and
Scott Posner, or either of them, as his or her true and lawful
attorneys-in-fact and agents with full power of substitution and
resubstitution, for him or her and in his or her name, place and
stead, in any and all capacities, to sign any or all amendments to
this Registration Statement, and to any related registration
statement filed under Securities and Exchange Commission Rule
462(b), and to file the same with all exhibits thereto, and all
documents in connection therewith, with the Securities and Exchange
Commission, granting said attorneys-in-fact and agents, and each of
them, full power and authority to do and perform each and every act
and thing requisite and necessary to be done, as fully to all
intents and purposes as he or she might or could do in person,
hereby ratifying and confirming all that said attorneys-in-fact and
agents, or any of them, or their or his or her substitute or
substitutes, may lawfully do or cause to be done by virtue
hereof.
Pursuant to the requirements of the Securities Act of 1933, as
amended, this Registration Statement has been signed below by the
following persons in the capacities and on the dates
indicated.
|
|
|
|
|
|
|
|
|
Signature |
Title |
Date |
/s/ John L. Garrison
John L. Garrison
|
Chairman, Chief Executive Officer and Director (Principal Executive
Officer)
|
August 4, 2020
|
/s/ John D. Sheehan
John D. Sheehan
|
Senior Vice President and Chief Financial Officer (Principal
Financial Officer)
|
August 7, 2020
|
/s/ Mark I. Clair
Mark I. Clair
|
Vice President, Controller and Chief Accounting Officer (Principal
Accounting Officer)
|
August 7, 2020
|
/s/ Paula H. J. Cholmondeley
Paula H. J. Cholmondeley
|
Director |
August 4, 2020
|
/s/ Don DeFosset
Don DeFosset
|
Director |
August 4, 2020
|
/s/ Thomas J. Hansen
Thomas J. Hansen
|
Director |
August 4, 2020
|
/s/ Raimund Klinkner
Raimund Klinkner
|
Director |
August 4, 2020
|
/s/ Sandie O'Conner
Sandie O’Connor
|
Director
|
August 5, 2020
|
/s/ Andra Rush
Andra Rush
|
Director
|
August 6, 2020
|
/s/ David A. Sachs
David A. Sachs
|
Lead Director |
August 6, 2020
|
EXHIBIT INDEX
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit Number |
|
|
|
|
|
Description of Document |
|
|
1.1** |
|
|
|
|
|
Form of Underwriting Agreement |
|
|
3.1 |
|
|
|
|
|
|
|
|
3.2 |
|
|
|
|
|
|
|
|
3.3 |
|
|
|
|
|
|
|
|
3.4 |
|
|
|
|
|
|
|
|
3.5 |
|
|
|
|
|
|
|
|
4.1 |
|
|
|
|
|
|
|
|
4.2 |
|
|
|
|
|
|
|
|
4.3** |
|
|
|
|
|
Form of Senior Debt Security |
|
|
4.4** |
|
|
|
|
|
Form of Subordinated Debt Security |
|
|
4.5** |
|
|
|
|
|
Form of Certificate of Designation of Preferred Stock |
|
|
4.6** |
|
|
|
|
|
Form of Depositary Agreement |
|
|
4.7** |
|
|
|
|
|
Form of Depositary Receipt |
|
|
4.8** |
|
|
|
|
|
Form of Securities Warrant |
|
|
5.1* |
|
|
|
|
|
|
|
|
23.1* |
|
|
|
|
|
|
|
|
23.2* |
|
|
|
|
|
|
|
|
24.1* |
|
|
|
|
|
|
|
|
25.1* |
|
|
|
|
|
|
|
|
25.2* |
|
|
|
|
|
|
|
|
|
|
|
* |
|
|
Filed herewith. |
|
|
|
|
|
** |
|
|
Executed versions of this agreement or item, if any, will be filed
by Current Report on Form 8-K after the issuance of the
securities to which they relate. |
|
|
|
|
|
|
|
|
|
|
|
Terex (NYSE:TEX)
Historical Stock Chart
From Dec 2020 to Jan 2021
Terex (NYSE:TEX)
Historical Stock Chart
From Jan 2020 to Jan 2021